STOCK TITAN

Can-Fite BioPharma Ltd. (CANF) Debt by Year

CANF NYSE

Can-Fite BioPharma Ltd. held $5.5M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Can-Fite BioPharma Ltd. has filed alongside them.

FY2025 annual
Long-Term Debt N/A
Cash & Equivalents $5.5M
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CANF Debt & Cash by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-F
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$5.5M+14.6%$4.8M+12.8%$4.3M+43.7%$3.0M-32.2%$4.4M-46.9%$8.3M+206.6%$2.7M-25.4%$3.6M+3.1%$3.5M-56.8%$8.1MN/A

CANF Debt & Cash by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ2'256-KQ4'2420-FQ2'246-KQ4'2320-FQ2'236-KQ4'2220-FQ2'226-KQ4'2120-FQ2'216-KQ4'2020-FQ2'206-K
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$5.5M+14.6%$6.5M+36.8%$4.8M+12.8%$4.7M+36.5%$4.3M+43.7%$3.5M+102.0%$3.0M-32.2%$1.7M-77.3%$4.4M-46.9%$7.5M-16.8%$8.3M+206.6%$9.1M

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Can-Fite BioPharma Ltd. financials

Frequently Asked Questions

Can-Fite BioPharma Ltd. held $5.5M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Can-Fite BioPharma Ltd. (CANF) reported on that line in every period on record.